Clinical Trials Logo

Clinical Trial Summary

Aerobic vaginitis was treated by using Baofukang Suppository 7 days group or Baofukang Suppository 14 days group.To evaluate the efficacy and safety after treatment.


Clinical Trial Description

Aerobic vaginitis was treated by using Baofukang Suppository 7 days group or Baofukang Suppository 14 days group. Group 1: Baofukang Suppository (1.74g), for vaginal use, 2 capsules per night for 7 days. Group 2: Baofukang Suppository (1.74g), for vaginal use, 2 capsules per night for 14 days. The efficacy and safety will be evaluated 7~14 days after treatment and 35~42 days after treatment. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04574089
Study type Interventional
Source Peking University Shenzhen Hospital
Contact Ping Liu, M.D.
Phone 86755-83923333
Email 253783006@qq.com
Status Recruiting
Phase Phase 3
Start date May 1, 2020
Completion date December 30, 2023

See also
  Status Clinical Trial Phase
Completed NCT02515656 - Assessment of the Efficacy of POLYGYNAX® in the Empirical Treatment of Infectious Vaginitis Phase 3
Recruiting NCT01420510 - Saginil in vs. Placebo for Gynecologic Oncology Patients Affected by Vaginitis Phase 2/Phase 3
Completed NCT04079218 - Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial Phase 4
Recruiting NCT05557318 - Using Micro Electro Mechanical Systems to Detect the Air of Vaginal Discharge N/A
Completed NCT01436513 - A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions. Phase 1
Completed NCT03585049 - Microscopic Images for the Development of a Rapid Vaginitis Diagnostic Device
Completed NCT04676503 - Vaginal and Rectal Colonization of Lactobacillus Crispatus NTCVAG04 Following Oral Administration in Patients With History of Vaginitis/Vaginosis N/A
Completed NCT02641717 - Validity of Patient-Collected Wet Mounts N/A
Recruiting NCT05587283 - Safety, Tolerability, and Acceptability Study of Intravaginal Administration of LABTHERA-001 Capsules in Healthy Women Phase 1
Not yet recruiting NCT06070454 - Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions N/A
Completed NCT02365389 - Once Daily In-situ Forming Versus Twice-daily Conventional Metronidazole Vaginal Gels for Treatment of Bacterial Vaginosis Phase 2/Phase 3
Completed NCT01050465 - MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use N/A
Completed NCT05652959 - Real-world Performance and Safety of Cerviron® in the Treatment of Vaginitis
Recruiting NCT02763696 - Establishment of a Sensitive System for Analysis of Child-bearing Women Vaginal Microbiota N/A
Recruiting NCT04816903 - Gyni™ Study With Leumit Health Services N/A
Completed NCT05670535 - Sjögren and Gynecologic Considerations
Enrolling by invitation NCT04984460 - Morphological Detection of Liquid-based Thin-layer Film-making Fungi for Fungal Vaginitis in Multiple Hospitals
Completed NCT03151928 - Diagnostic Accuracy By Providers Study
Completed NCT05396261 - a Flexible Wound Dressing for the Management of Genital Skin Conditions N/A
Completed NCT00803127 - VS-Sense Result Reading Clarity N/A